Liraglutide: what the oldest GLP-1 ingredient for weight loss delivers

By the Doktorly editorial team · Medically reviewed by the Doktorly medical team · Last updated: 27 October 2026

Liraglutide was the first GLP-1 ingredient approved in the EU explicitly for weight reduction – long before Ozempic made the headlines. Today it is regarded as the "reduced-strength" option: somewhat weaker in effect, but by far the longest established.

One ingredient, two brands

Both products contain liraglutide from Novo Nordisk. For losing weight, Saxenda is the relevant product; Victoza would be an off-label use.

Why daily instead of weekly?

Liraglutide stays active in the body for only about 13 hours – too short for a weekly injection. That is why it is injected once daily. The advantage: the effect can be dosed finely and reduced quickly if side effects occur. The disadvantage: daily injections and higher pen consumption.

What the studies show

In the SCALE trial, participants on liraglutide 3 mg lost on average about 8 % of their weight over one year, versus about 2.6 % on placebo. The Lancet: SCALE (2015). Newer ingredients exceed that: semaglutide reached about 15 % in comparable designs, tirzepatide even about 20 %.

For whom is liraglutide still a good choice?

Saxenda can still make sense if you:

The full comparison of all ingredients is available here: weight-loss injections compared.

Side effects

Frequently asked questions about liraglutide

Frequently asked questions

Can Victoza be used for weight loss?

Victoza is approved only for type 2 diabetes. Prescribing it for weight loss would be off-label – the 3 mg product Saxenda is the one intended for weight management.

How long does the dose build-up take?

About five weeks: the dose rises weekly from 0.6 mg up to the target dose of 3.0 mg daily.

What are the monthly costs?

Roughly 330–400 € for self-payers, since it is injected daily and more pen content is used.

Do people regain weight after stopping?

Weight regain is possible and was frequently observed in studies. Sustainable nutrition and exercise habits plus medical follow-up are important.

Sources